The Ott Lab publishes novel research on SARS-CoV-2 variants Read More

Ott Lab News

Dr. Melanie Ott featured in New York Times, SF Business Times articles

Dr. Ott made her New York Times debut in the article “Monster or Machine? A Profile of the Coronavirus at 6 Months”, by Alan Burdick. You can read the full article here: https://www.nytimes.com/2020/06/02/health/coronavirus-profile-covid.html.

Dr. Ott was also recently profiled by the San Francisco Business Times, and that article can be found here: https://www.bizjournals.com/sanfrancisco/news/2020/05/29/inspire-awards-melanie-ott-leads-research-in-covid.html.

Dr. Melanie Ott Collaborates on COVID-19 Research

Dr. Ott is part of a team at Gladstone researching SARS-CoV-2. She is working with Dr. Jennifer Doudna to develop a CRISPR-based method to rapidly measure COVID-19 RNA. By combining the technique with iPhone technology, they aim to develop a diagnostic that could deliver rapid results and be widely deployed even far from traditional labs, such as in airports and other ports of entry, and in remote communities throughout the world. More info on Gladstone’s COVID-19 research can be found here: https://gladstone.org/news/gladstone-institutes-responds-covid-19-pandemic.